Six months ago, Andrew Witty, long-time CEO of Britains largest drug maker GlaxoSmithKline, announced he would...
Up to date
Appointments
German molecular diagnostics specialist GNA Biosolutions GmbH has appointed Frank Krieg-Schneider as its...
Swedish Gyros Protein Technologies AB, which was formed in spring by merging nanoliter-scale immunoassay...
Galvani Bioelectronics, the developer of bioelectronic medicines launched by GlaxoSmithKline and Alphabet’s...
French biopharma company Pharnext has appointed René Goedkoop as its new Chief Medical Officer. He joins the...
Matthias Schroff, erstwhile CEO of Mologen, has taken over the helm of immunotherapy developer Vaximm AG. The...
Share
